Appeal dismissed in pregabalin patent case
The England & Wales Court of Appeal has upheld Mr Justice Arnold's finding that key claims of Warner-Lambert's patent for Lyrica are invalid for insufficiency. The judgment also reiginites the debate over the scope of second medical use patents
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
